摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

lycoposerramine Z | 927813-34-1

中文名称
——
中文别名
——
英文名称
lycoposerramine Z
英文别名
(4aR,5R,7R,8aS)-7-methyl-5-[(1-oxido-2,3,4,5-tetrahydropyridin-1-ium-6-yl)methyl]-1,2,3,4,4a,5,6,7,8,8a-decahydroquinoline
lycoposerramine Z化学式
CAS
927813-34-1
化学式
C16H28N2O
mdl
——
分子量
264.411
InChiKey
LOKZTKJBSRMBJH-XOUADPBQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    40.8
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    C22H33NO5盐酸 、 palladium 10% on activated carbon 、 C32H11F10O4P 、 盐酸羟胺氢气potassium carbonatemagnesium三乙胺三氟乙酸 作用下, 以 四氢呋喃甲醇乙醇二氯甲烷甲苯 为溶剂, 反应 84.25h, 生成 lycoposerramine Z
    参考文献:
    名称:
    手性磷酸催化分子内迈克尔加成对映体合成Lycoposerramine-Z
    摘要:
    phlegmarine型的新的对映选择性全合成石松生物碱lycoposerramine-Z(1)已经完成,使用一锅两个不同的格氏试剂的化学选择性相继添加到双-的Weinreb酰胺中间体和完全官能化的环己酮的一种有效的结构中间体与手性磷酸催化的对映选择性分子内迈克尔加成反应。
    DOI:
    10.1021/acs.joc.5b02723
点击查看最新优质反应信息

文献信息

  • <i>cis</i>-Decahydroquinolines via Asymmetric Organocatalysis: Application to the Total Synthesis of Lycoposerramine Z
    作者:Ben Bradshaw、Carlos Luque-Corredera、Josep Bonjoch
    DOI:10.1021/ol303257y
    日期:2013.1.18
    A concise synthesis of the Lycopodium alkaloid lycoposerramine Z is reported. Key to the strategy is a one-pot organocatalyzed Michael reaction followed by a domino Robinson annulation/intramolecular aza-Michael reaction promoted by LiOH, leading to enantiopure cis-decahydroquinolines.
    据报道,Lycopodium生物碱lycoposerramine Z的简明合成。该策略的关键是一锅有机催化的Michael反应,然后是LiOH促进的多米诺骨牌Robinson环化/分子内氮杂-Michael反应,从而导致对映体纯的顺式十氢喹啉。
  • Asymmetric Total Syntheses of Cyclic Nitrone-Containing Phlegmarine-Type <i>Lycopodium</i> Alkaloids, Lycoposerramines-X and -Z
    作者:Tomoyuki Tanaka、Noriyuki Kogure、Mariko Kitajima、Hiromitsu Takayama
    DOI:10.1021/jo9018182
    日期:2009.11.20
    The total syntheses of cyclic nitrone-containing phlegmarine-type Lycopodium alkaloids, lycoposerramines-X and -Z, were accomplished starting from (R)-3-methylcyclohexanone via Pd-catalyzed Suzuki−Miyaura coupling, Johnson−Claisen rearrangement, stereoselective hydroboration−oxidation reaction, and Mitsunobu reaction, thereby establishing the structures including the absolute configuration.
    含有环状硝酮phlegmarine型的全合成石松生物碱,lycoposerramines-X和-Z,分别实现了从(起始- [R)-3-甲基环己酮通过Pd-催化的Suzuki-Miyaura偶联,约翰逊-Claisen重排,立体选择性硼氢化-氧化反应和光延反应,从而建立了包括绝对构型在内的结构。
  • Enantioselective Total Synthesis of Lycoposerramine-Z Using Chiral Phosphoric Acid Catalyzed Intramolecular Michael Addition
    作者:Lan-De Zhang、Lin-Rui Zhong、Jie Xi、Xiao-Liang Yang、Zhu-Jun Yao
    DOI:10.1021/acs.joc.5b02723
    日期:2016.3.4
    A new enantioselective total synthesis of phlegmarine-type Lycopodium alkaloid lycoposerramine-Z (1) has been accomplished, using one-pot chemoselective sequential additions of two different Grignard reagents to the bis-Weinreb-amide intermediate and an efficient construction of the fully fuctionalized cyclohexanone intermediate with a chiral phosphoric acid catalyzed enantioselective intramolecular
    phlegmarine型的新的对映选择性全合成石松生物碱lycoposerramine-Z(1)已经完成,使用一锅两个不同的格氏试剂的化学选择性相继添加到双-的Weinreb酰胺中间体和完全官能化的环己酮的一种有效的结构中间体与手性磷酸催化的对映选择性分子内迈克尔加成反应。
查看更多

同类化合物

锯齿石松宁 箭毒蛙毒素 C 坎库碘铵 十氢喹啉 十氢-2-甲基喹啉 八氢对苯二酚-4(1H)-酮 八氢喹啉-2(1H)-酮 八氢-2,6-喹啉二酮 [(4aS,4bR,6aS,8S,10aS,10bS,12aS)-10a,12a-二甲基-1,2,3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十六氢萘并[6,5-f]喹啉-8-基]2-[4-[二(2-氯乙基)氨基]苯基]乙酸酯 [(4aS,4bR,6aS,8S,10aS,10bS,12aS)-1,10a,12a-三甲基-2-氧代-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十四氢萘并[6,5-f]喹啉-8-基]2-[4-[二(2-氯乙基)氨基]苯基]乙酸酯 8H-13,3,6a-乙基亚基-7,10-亚甲基噁庚并[3,4-i]-1-苯并吖辛因-8-酮,1-乙基十四氢-12a-羟基-6-甲氧基-3-甲基-,(3R,6S,6aS,7R,7aS,10S,12aS,13S,13aR,15R)-(9CI) 8-羟基-十氢喹啉 4-乙炔基-2-甲基十氢喹啉-4-醇 3-羟基-13,17-开环-5-雄甾烯-17-酸-13,17-内酰胺(4-(二(2-氯乙基)氨基)苯基)丁酸酯 2,5-二丙基十氢喹啉 1-(3-氯-丙基)-十氢-喹啉 1,2,2-三甲基-八氢-喹啉-4-酮 (4aS,4bR,8S,10aR,10bS,12aS)-10a,12a-二甲基-2-羰基-1,2,3,4,4a,4b,5,7,8,9,10,10a,10b,11,12,12a-十六氢萘并[2,1-f]喹啉-8-基{4-[二(2-氯乙基)氨基]苯基}乙酸酯 (4aS,4bR,6aS,8S,10aS,10bS,12aS)-8-羟基-10a,12a-二甲基-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-十四氢-1H-萘并[2,1-f]喹啉-2-酮 (3S,13R)-1,2,3,4,4aalpha,5,11,11aalpha-八氢-2,2,5-三甲基-3beta,5beta-乙桥-10bH-吡啶并[3,2-b]咔唑-10bbeta,13-二醇 (3R,6S,6aS,7R,7aS,10S,12aS,13R,13aR,14S,15R)-1-乙基十四氢-12a,14-二羟基-6-甲氧基-3-甲基-8H-13,3,6a-亚乙基-7,10-甲桥氧杂卓并[3,4-i]-1-苯并氮杂环辛四烯-8-酮 (2S,4aR,8aR)-2-甲基八氢-4(1H)-喹啉酮 (2R,4R,4As,8As)-rel-4-乙炔基十氢-1,2-二甲基-4-喹啉醇 (4aS,5R,8aR)-1-(tert-butoxy)carbonyl-2-oxo-5-(triisopropylsilyloxymethyl)decahydroquinoline trans-(+/-)-1-n-propyl-7-oxodecahydroquinoline 3,4,5,6,6a,7,8,9,10,10a-decahydro-(4aβH)-benzo[c]quinolizin-3-one 3,4,5,6,6a,7,8,9,10,10a-decahydro-(4aαH)-benzo[c]quinolizin-3-one 3,4,4a,5,6,7,8-heptahydro-8a-hydrodioxy-2(1H)-quinolinone [2-(2,3-dichloro-phenyl)-thiazol-4-yl]-(octahydro-quinolin-1-yl)-methanone (octahydro-quinolin-1-yl)-(2-pyridin-3-yl-thiazol-4-yl)-methanone 2-methylperhydrothiazolo<2,3-j>quinoline 2,4-dichloro-N-[5-((4aRS,8aSR)-octahydroquinoline-1-carbonyl)pyridin-2-yl]benzamide (4aR*,5S*,8aR*)-1,2,3,4,4a,5,6,7,8,8a-Decahydro-5-<(dimethylphenylsilyl)methyl>-1-methylquinoline (4aS*,5S*,8aR*)-1,2,3,4,4a,5,6,7,8,8a-Decahydro-5-<(dimethylphenylsilyl)methyl>-1-(methoxycarbonyl)quinoline (2S,3R,4aS,5R,8aR)-1-(tert-butoxy)carbonyl-3-hydroxy-2-methyl-5-(triisopropylsilyloxymethyl)decahydroquinoline (+/-)-(2SR,4aRS,8aRS)-1-tert-butyloxycarbonyl-5-methylene-2-propyldecahydroquinoline (+/-)-(2SR,4aRS,8aRS)-1-tert-butyloxycarbonyl-2-propyldecahydroquinolin-5-one cis-4-[4-(octahydro-quinoline-1(2H)-ylcarbonyl)-thiophen-2-yl]-piperidine-1-carboxylic acid amide lepadin E (+)-lepadin D cis-(octahydro-quinolin-1(2H)-yl)-(5-piperidin-4-yl-thiophen-3-yl)-methanone 4-methyl-6-(3-methyl-2-thienyl)-4,5,6,7-tetrahydroquinolin-5-one 2,2,4,8-tetramethyldecahydroquinoline 10-oxo-2,5;5,9-diseco-A-dinor-strychnidine-2,5-dioic acid strychnidine-2,3,10-trione 3-tetrazolo-17a-aza-D-homo-3,5-androstadien-17-one 17a-methyl-3-tetrazolo-17a-aza-D-homo-3,5-androstadien-17-one methyl 4-oxooctahydroquinoline-1(2H)-carboxylate decahydro-2-oxo-8-quinolinepropanoic acid ethyl ester 1-octahydro[1]quinolyl-propan-2-ol